NextPlat Corp (NASDAQ:NXPL – Get Free Report) was the target of a significant drop in short interest during the month of September. As of September 15th, there was short interest totalling 118,300 shares, a drop of 15.4% from the August 31st total of 139,900 shares. Approximately 1.3% of the company’s shares are short sold. Based on an average daily volume of 120,000 shares, the days-to-cover ratio is presently 1.0 days.
NextPlat Trading Up 0.7 %
NXPL traded up $0.01 on Friday, reaching $1.42. 25,010 shares of the company traded hands, compared to its average volume of 328,389. The company has a market cap of $26.94 million, a P/E ratio of -5.68 and a beta of 0.89. The company has a quick ratio of 2.93, a current ratio of 3.30 and a debt-to-equity ratio of 0.03. NextPlat has a one year low of $0.99 and a one year high of $2.68. The firm has a fifty day simple moving average of $1.22 and a two-hundred day simple moving average of $1.24.
NextPlat (NASDAQ:NXPL – Get Free Report) last announced its quarterly earnings results on Wednesday, August 14th. The company reported $0.24 earnings per share (EPS) for the quarter. NextPlat had a positive return on equity of 29.57% and a negative net margin of 7.59%. The firm had revenue of $16.99 million during the quarter.
About NextPlat
NextPlat Corp operates as a healthcare and e-commerce company in Europe, North America, South America, the Asia and Pacific, and Africa. The company operates full-service retail specialty services pharmacies that provides prescription pharmaceuticals prescription pharmaceuticals, third-party administration, risk and data management services, compounded medications, tele-pharmacy services, anti-retroviral medications, medication therapy management, contracted pharmacy services, and health practice risk management to healthcare organizations and providers, as well as supplies prescription medications to long-term care facilities.
Further Reading
- Five stocks we like better than NextPlat
- What is the Nikkei 225 index?
- CarMax’s Impressive Rally: What Investors Should Watch Next
- Should You Add These Warren Buffett Stocks to Your Portfolio?
- MarketBeat Week in Review – 9/23 – 9/27
- Dividend King Proctor & Gamble Is A Buy On Post-Earnings Weakness
- Wake Up to This Biotech Stock That Still Has Big Potential Upside
Receive News & Ratings for NextPlat Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NextPlat and related companies with MarketBeat.com's FREE daily email newsletter.